RSS   Newsletter   Contact   Advertise with us

Vedanta Biosciences appoints new chief scientific officer

Staff writer | Boston, Mass., USA | March 17, 2016
Vedanta BiosciencesMarch 17, 2016, Boston, Mass., USA - Vedanta Biosciences, a microbiome company, announced the appointment of former Genzyme group vice president, Bruce L. Roberts, as chief scientific officer.
Dr. Roberts has 30 years of experience in biotechnology and pharmaceutical drug discovery and development.

He most recently served as head of Neuro-Immunology and Immune-Mediated Disease Research at Sanofi Genzyme where he directed pre-clinical efforts resulting in the introduction of therapeutic antibodies, gene therapies, cell therapies and small molecules into multiple clinical trials for the treatment of cancer, multiple sclerosis and autoimmunity.

He directed research efforts in support of several approved products including lemtrada, aubagio, thymoglobulin, Mozobil, alemtuzumab, leukine, chlofarabine and fludarabine and contributed to the generation of ecallantide.

He has authored more than fifty peer-reviewed publications and contributed to several issued patents and patent applications.

 LATEST MOVES FROM Massachusetts